Abdulrazaq Al Jazairi PharmD, MBA

Dr. Al-Jazairi is a Clinical Pharmacy Consultant in the field of Cardiovascular Pharmacotherapy. Dr. Al-Jazairi is the Director of the Cardiovascular Pharmacotherapy Specialty Residency Program at King Faisal Specialist Hospital and Research Center (KFSH&RC). He received his Doctor of Pharmacy degree from Campbell University at Buies Creek, North Carolina, USA, and a general Pharmacy Practice Residency at Duke University Medical Center (DUMC), Durham, NC.
In 2000, Dr. Al-Jazairi completed a two-year Specialty Residency in Cardiovascular Pharmacotherapy from Philadelphia College of Pharmacy, University of the Sciences in Philadelphia in conjunction with the Hospital University of Pennsylvania (HUP), Philadelphia and Pennsylvania. More recently Dr. Al-Jazairi earned a Master in Pharmaceutical and Healthcare Business from Mayes College, University of the Sciences in Philadelphia. Dr. Al-Jazairi is a board certified pharmacotherapy specialist with Cardiology added-qualification.
Dr. Al-Jazairi has several national and international presentations as well as more than 20 original publications. Dr. Al-Jazairi is an editorial board member of prime journals, including Annals of Pharmacotherapy and the Annals of Saudi Medicine, for more than 10 years. He is also chairing the Clinical Research Committee in the Research Center at King Faisal Specialist Hospital- Riyadh for a second term, and setting in several other critical committees.
He is a member of the Board of Pharmacy, in the Saudi Commission for Health Specialists, and a Chairman of the Examination Committee. He sets in several committees in Saudi-FDA. He also serves as an Associate Professor, School of Pharmacy, at Qassim University, and adjunct Assistant Professor in King Saud University and Princess Nora University, Riyadh, Saudi Arabia.